1465326-89-9

Basic information

• Product Name: methyl 3,5-dichloro-4-formylbenzoate
• CAS NO: 1465326-89-9
• Molecular Weight: 233.051
• Mol File: 1465326-89-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 347.9±42.0 °C(Predicted)
• Density: 1.430±0.06 g/cm3(Predicted)
• CAS DataBase Reference: methyl 3,5-dichloro-4-formylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3,5-dichloro-4-formylbenzoate(1465326-89-9)
• EPA Substance Registry System: methyl 3,5-dichloro-4-formylbenzoate(1465326-89-9)

Safety Data

• Hazardous Substances Data: 1465326-89-9(Hazardous Substances Data)

Upstream product

• 39652-34-1 3,5-dichloro-4-methylbenzoic acid 
• 203573-09-5 methyl-3,5-dichloro-4-methylbenzoate 
• 859212-75-2 methyl 4-(bromomethyl)-3,5-dichlorobenzoate 
• 51-36-5 3,5-dichlorobenzoic acid 
• 67-56-1 methanol 
• 153203-80-6 3,5-dichloro-4-formylbenzoic acid 
• 1571-08-0 methyl 4-formylbenzoate 

Relevant articles and documents

A kind of the second aryl amine derivative and its preparation method, pharmaceutical composition and use thereof

The invention provides diarylamide type derivatives having a structure shown as a formula (I) as follows, or pharmaceutically acceptable salts thereof, a preparing method of the derivatives, compositions containing the derivatives and the pharmaceutically acceptable salts, and medicine uses of the derivatives and the pharmaceutically acceptable salts. The diarylamide type derivatives having the structure shown as the formula (I) or the pharmaceutically acceptable salts thereof have antagonistic effects on FXR. Integral animal experiments show that the compounds have effects of decreasing blood sugar and reducing blood fat. The compounds can be used for treating hyperlipidemia and type 2 diabetes mellitus.

Efficient three-component synthesis of diversely substituted tetrahydro-1H-cyclopenta[c]quinolines

The synthesis of highly functionalized substituted tetrahydro-1H-cyclopenta[c]quinoline (I) and its reduced derivatives hexahydro-1H-cyclopenta[c]quinolines (II) via Povarov reaction in high diastereoselectivity and high to moderate yields is described he

SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.